Dr. Rivner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3351 Northside Dr
Macon, GA 31210Phone+1 478-201-6629Fax+1 706-721-8701
Education & Training
Medical College of GeorgiaFellowship, Pain Medicine, 1982 - 1983- Medical College of GeorgiaResidency, Neurology, 1978 - 1982
Emory University School of MedicineClass of 1978
Certifications & Licensure
GA State Medical License 1979 - 2025
SC State Medical License 1980 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Gilenya in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
- Clinical Trial of Ezogabine (Retigabine) in ALS Subjects Start of enrollment: 2015 Jun 01
- Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS Start of enrollment: 2020 May 28
Publications & Presentations
PubMed
- 13 citationsEffects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trialMichael D. Weiss, Eric A. Macklin, Courtney E. McIlduff, Steve Vucic, Brian J. Wainger
Muscle & Nerve. 2021-03-01 - 179 citationsInfluence of age and height on nerve conduction.Michael H. Rivner, Thomas R. Swift, Khalid Malik
Muscle & Nerve. 2001-09-01 - 11 citationsRandomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.J R Mendell, R J Barohn, M L Freimer, J T Kissel, W King
Neurology. 2001-02-27
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
Press Mentions
'This Is Horrible': Future of Central and South Georgia's Only Clinic for ALS Patients UncertainOctober 26th, 2022- Augusta Clinic, MCG Student Focus on Patient, Family in Treatment of ALSMay 21st, 2021
- 1st Patient Enrolled in Phase 2a Trial Testing AT-1501 in ALSNovember 4th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
